Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings | 1.46% | $452.11K | $2.22B | 11.49% | 81 Outperform | |
| Flowserve | 1.39% | $431.72K | $9.06B | 22.93% | 79 Outperform | |
| Progyny | 1.32% | $409.68K | $2.20B | 52.66% | 79 Outperform | |
| Woodward | 1.25% | $386.42K | $18.79B | 83.26% | 79 Outperform | |
| Cactus | 1.24% | $385.98K | $3.67B | -19.66% | 77 Outperform | |
| New York Times | 1.24% | $383.42K | $11.53B | 31.90% | 79 Outperform | |
| Lantheus | 1.19% | $368.44K | $4.42B | -27.54% | 73 Outperform | |
| Catalyst Pharma | 1.17% | $363.89K | $3.01B | 13.41% | 83 Outperform | |
| Exelixis | 1.17% | $361.78K | $12.47B | 36.76% | 78 Outperform | |
| Mercury General | 1.17% | $361.61K | $5.24B | 40.26% | 69 Neutral |